Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts Attenuates Joint Inflammation in Collagen Antibody-Induced Arthritis.

Tu J, Zhang Y, Kim S, Wiebe E, Spies CM, Buttgereit F, Cooper MS, Seibel MJ, Zhou H.

Am J Pathol. 2016 May;186(5):1293-301. doi: 10.1016/j.ajpath.2015.12.025. Epub 2016 Mar 14.

PMID:
26988651
2.

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.

Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M, Dasgupta B, Dixon WG, Geenen R, Huizinga TW, Kent A, de Thurah AL, Listing J, Mariette X, Ray DW, Scherer HU, Seror R, Spies CM, Tarp S, Wiek D, Winthrop KL, Buttgereit F.

Ann Rheum Dis. 2016 Jun;75(6):952-7. doi: 10.1136/annrheumdis-2015-208916. Epub 2016 Mar 1. Review.

PMID:
26933146
3.

Novel glucocorticoids: where are we now and where do we want to go?

Buttgereit F, Spies CM, Bijlsma JW.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S29-33. Epub 2015 Oct 12. Review.

PMID:
26457359
4.

Circadian rhythms in rheumatology--a glucocorticoid perspective.

Spies CM, Straub RH, Cutolo M, Buttgereit F.

Arthritis Res Ther. 2014 Nov 13;16 Suppl 2:S3. doi: 10.1186/ar4687. Review.

5.

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.

Cutolo M, Spies CM, Buttgereit F, Paolino S, Pizzorni C.

Arthritis Res Ther. 2014 Nov 13;16 Suppl 2:S1. doi: 10.1186/ar4685. Review.

6.

Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study.

Spies CM, Hoff P, Mazuch J, Gaber T, Maier B, Strehl C, Hahne M, Jakstadt M, Huscher D, Burmester GR, Detert J, Kramer A, Buttgereit F.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):34-43. Epub 2014 Dec 22.

PMID:
25535886
7.

How to mechanistically explain the CONDOR study data.

Spies CM, Stemmler E, Buttgereit F.

Med Hypotheses. 2015 Jan;84(1):14-9. doi: 10.1016/j.mehy.2014.11.007. Epub 2014 Nov 15.

PMID:
25433956
8.

Acute murine antigen-induced arthritis is not affected by disruption of osteoblastic glucocorticoid signalling.

Spies CM, Wiebe E, Tu J, Li A, Gaber T, Huscher D, Seibel MJ, Zhou H, Buttgereit F.

BMC Musculoskelet Disord. 2014 Feb 3;15:31. doi: 10.1186/1471-2474-15-31.

9.

High-sensitivity immunofluorescence staining: a comparison of the liposome procedure and the FASER technique on mGR detection.

Strehl C, Gaber T, Jakstadt M, Hahne M, Hoff P, Spies CM, Scheffold A, Burmester GR, Buttgereit F.

J Fluoresc. 2013 May;23(3):509-18. doi: 10.1007/s10895-013-1163-4. Epub 2013 Feb 14.

PMID:
23408089
10.

Energy metabolism and rheumatic diseases: from cell to organism.

Spies CM, Straub RH, Buttgereit F.

Arthritis Res Ther. 2012 Jun 29;14(3):216. doi: 10.1186/ar3885. Review.

11.

Glucocorticoids.

Spies CM, Strehl C, van der Goes MC, Bijlsma JW, Buttgereit F.

Best Pract Res Clin Rheumatol. 2011 Dec;25(6):891-900. doi: 10.1016/j.berh.2011.11.002. Review.

PMID:
22265268
12.

Prednisone chronotherapy.

Spies CM, Cutolo M, Straub RH, Burmester GR, Buttgereit F.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S42-5. Epub 2011 Oct 21. Review.

PMID:
22018182
13.

Pharmacodynamics of glucocorticoids.

Strehl C, Spies CM, Buttgereit F.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S13-8. Epub 2011 Oct 21. Review.

PMID:
22018178
14.

Origin and functional activity of the membrane-bound glucocorticoid receptor.

Strehl C, Gaber T, Löwenberg M, Hommes DW, Verhaar AP, Schellmann S, Hahne M, Fangradt M, Wagegg M, Hoff P, Scheffold A, Spies CM, Burmester GR, Buttgereit F.

Arthritis Rheum. 2011 Dec;63(12):3779-88. doi: 10.1002/art.30637.

15.

Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica.

Spies CM, Burmester GR, Buttgereit F.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S172-7. Epub 2010 Oct 28. Review.

PMID:
21044455
16.

Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells.

Spies CM, Gaber T, Hahne M, Naumann L, Tripmacher R, Schellmann S, Stahn C, Burmester GR, Radbruch A, Buttgereit F.

Immunol Lett. 2010 Jun 15;131(1):24-32. doi: 10.1016/j.imlet.2010.03.009. Epub 2010 Apr 2.

PMID:
20363256
17.

More night than day--circadian rhythms in polymyalgia rheumatica and ankylosing spondylitis.

Spies CM, Cutolo M, Straub RH, Burmester GR, Buttgereit F.

J Rheumatol. 2010 May;37(5):894-9. doi: 10.3899/jrheum.091283. Epub 2010 Apr 1. Review.

PMID:
20360185
18.

Effects of hypoxia and/or lack of glucose on cellular energy metabolism and cytokine production in stimulated human CD4+ T lymphocytes.

Dziurla R, Gaber T, Fangradt M, Hahne M, Tripmacher R, Kolar P, Spies CM, Burmester GR, Buttgereit F.

Immunol Lett. 2010 Jun 15;131(1):97-105. doi: 10.1016/j.imlet.2010.02.008. Epub 2010 Mar 3.

PMID:
20206208
19.

Pharmacology of glucocorticoids in rheumatoid arthritis.

Spies CM, Bijlsma JW, Burmester GR, Buttgereit F.

Curr Opin Pharmacol. 2010 Jun;10(3):302-7. doi: 10.1016/j.coph.2010.02.001. Epub 2010 Mar 2. Review.

PMID:
20202903
20.

Analyses of similarities and differences in glucocorticoid therapy between rheumatoid arthritis and ankylosing spondylitis - a systematic comparison.

Spies CM, Burmester GR, Buttgereit F.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S152-8. Review.

PMID:
19822064
Items per page

Supplemental Content

Loading ...
Write to the Help Desk